Hypera S.A. (OTCMKTS:HYPMY) Short Interest Up 10.8% in March

Hypera S.A. (OTCMKTS:HYPMY) was the recipient of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 17,400 shares, an increase of 10.8% from the February 29th total of 15,700 shares. Based on an average trading volume of 10,500 shares, the days-to-cover ratio is currently 1.7 days.

Hypera Trading Down 6.5 %

Shares of OTCMKTS:HYPMY opened at $6.26 on Tuesday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.38 and a current ratio of 1.89. The firm has a fifty day moving average price of $6.67 and a 200 day moving average price of $6.92. Hypera has a fifty-two week low of $5.93 and a fifty-two week high of $10.08.

About Hypera

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.